Leber Congenital Amaurosis Inherited Blindness of Gene Therapy Trial(LIGHT)

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2028

Conditions
Leber Congenital Amaurosis
Interventions
GENETIC

HG004

Method of Administration: Once unilateralsubretinal injection; The duration of the study isabout 60 weeks for each subject including a 8-weekscreening period, enrollment/baseline visit,treatment visit, and 52 weeks follow-up period.

Trial Locations (1)

Unknown

Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySchool of Medicine, Shanghai

Sponsors
All Listed Sponsors
collaborator

HuidaGene Therapeutics Co., Ltd.

INDUSTRY

lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER